- Filed
- May 3, 2023 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2023 · Mar 6, 2023 | 465.62M sh |
| Capex | Q1 2023 · Nov 30, 2022 | $0 |
| Capex | Q1 2023 · Nov 30, 2021 | $65.08K |
| Operating Cash Flow restated | Q1 2023 · Nov 30, 2022 | −$1.04M |
| Operating Cash Flow | Q1 2023 · Nov 30, 2021 | −$2.01M |
| Cash And Equivalents | Q1 2023 · Nov 30, 2022 | $175.26K |
| Cash And Equivalents | Q1 2023 · Aug 31, 2022 | $382.43K |
| Stockholders Equity restated | Q1 2023 · Nov 30, 2022 | −$1.49M |
| Stockholders Equity | Q1 2023 · Aug 31, 2022 | $629.6K |
| Stockholders Equity | Q1 2023 · Nov 30, 2021 | $3.45M |
| Stockholders Equity | Q1 2023 · Aug 31, 2021 | $1.91M |
| Current Liabilities restated | Q1 2023 · Nov 30, 2022 | $2.76M |
| Current Liabilities | Q1 2023 · Aug 31, 2022 | $2.97M |
| Total Liabilities restated | Q1 2023 · Nov 30, 2022 | $4.94M |
| Total Liabilities | Q1 2023 · Aug 31, 2022 | $3.25M |
| Current Assets | Q1 2023 · Nov 30, 2022 | $684.04K |
| Current Assets | Q1 2023 · Aug 31, 2022 | $1.01M |
| Total Assets restated | Q1 2023 · Nov 30, 2022 | $3.45M |
| Total Assets | Q1 2023 · Aug 31, 2022 | $3.88M |
| Sga Expense restated | Q1 2023 · Nov 30, 2022 | $224.67K |
| Sga Expense | Q1 2023 · Nov 30, 2021 | $336.67K |
| Net Income restated | Q1 2023 · Nov 30, 2022 | −$990.24K |
| Net Income | Q1 2023 · Nov 30, 2021 | −$513.79K |
| Operating Income restated | Q1 2023 · Nov 30, 2022 | −$746.56K |
| Operating Income | Q1 2023 · Nov 30, 2021 | −$593.57K |
| Gross Profit | Q1 2023 · Nov 30, 2022 | $424.3K |
| Gross Profit | Q1 2023 · Nov 30, 2021 | $429.44K |
| Cost Of Revenue | Q1 2023 · Nov 30, 2022 | $1.03M |
| Cost Of Revenue | Q1 2023 · Nov 30, 2021 | $23.05K |